International Clinical Trial: Study to Evaluate the Efficacy and Safety of Fexuprazan in Prevention of NSAIDs Induced Peptic Ulcer

Geneva, April 27 -- International Clinical Trials Registry received information related to the study (NCT07533266) titled 'Study to Evaluate the Efficacy and Safety of Fexuprazan in Prevention of NSAIDs Induced Peptic Ulcer' on April 8.

Study Type: Interventional

Study Design: Allocation: Randomized. Intervention model: Parallel Assignment. Primary purpose: Prevention. Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor).

Primary Sponsor: Daewoong Pharmaceutical Co. LTD.

Condition: NSAID (Non-Steroidal Anti-Inflammatory Drug)

Intervention: Drug: Fexuprazan 20mg Drug: Lansoprazole 15 mg placebo Drug: Lansoprazole 15 mg

Recruitment Status: Not recruiting

Phase: Phase 4

Date of First Enrollment: April...